Bri Ladd

AppliedVR is unleashing the power of Immersive Therapeutics (ITx), a new category of medical devices that harness the unique properties of virtual reality (VR) to treat some of the most debilitating chronic conditions. AppliedVR’s easy-to-use and engaging non-pharmacological platform enables patients to access our validated therapies from the comfort of home. The Company’s flagship product, RelieVRx®, is the first VR-based FDA-authorized medical device to treat chronic lower back pain (CLBP), a condition that affects 72 million adults in the US alone. RelieVRx has achieved multiple industry firsts including a unique CMS code and coverage category, paving the pathway to broad accessibility. Learn more about AppliedVR, headquartered in Los Angeles, at appliedvr.io. AppliedVR’s RelieVRx® program optimizes the proven benefits of cognitive behavioral therapy (CBT) through a sequential, immersive therapeutic program which activates the brain’s innate healing power. Rigorously validated to reduce pain and pain intensity in multiple clinical trials totaling over 1,200 patients, RelieVRx is the first prescription virtual reality medical device to receive Breakthrough Device Designation and De Novo authorization by the FDA for the treatment of chronic lower back pain. For more information, visit relievrx.com.